FDA Inspection 1144555 — Seattle Reproductive Medicine, Inc., P.S.
The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on June 16, 2021 in Spokane Valley, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Spokane Valley, WA (United States)